Sanofi terminates deal on drug license after US FTC objects
WASHINGTON (Reuters) – Sanofi said on Monday it was terminating
sanofi
Sanofi to explore acquisition of cancer drugmaker Mirati- Bloomberg News
(Reuters) – Paris-based drugmaker Sanofi is exploring a potential acquisition
Sanofi lifts earnings outlook on new drug launches, Dupixent sales
By Ludwig Burger (Reuters) -French drugmaker Sanofi on Friday increased
Amgen emerges frontrunner in Horizon deal as Sanofi drops bid
(Reuters) -Amgen Inc is in advanced talks to buy biotech
Sanofi and Regeneron present more positive data for Dupixent product
PARIS (Reuters) – Healthcare companies Sanofi and partner Regeneron presented
French drugmaker Sanofi expects positive boost from currency markets in Q3
PARIS (Reuters) -French drugmaker Sanofi said it expected a positive
Analysis-Meagre medicine cabinet leaves Sanofi unloved
By Ludwig Burger FRANKFURT (Reuters) – Sanofi’s recent stock rout
Sanofi CFO says stock price pummelling grossly overdone
FRANKFURT (Reuters) – Sanofi’s finance chief said on Wednesday that
China’s Innovent Biologics secures over $300 million investment from Sanofi
(Reuters) – Innovent Biologics Inc said on Friday Paris-based Sanofi
Sanofi caps out-of-pocket insulin cost at $35 for uninsured U.S. patients
(Reuters) – French drugmaker Sanofi said on Wednesday uninsured diabetes
Sanofi ordered to compensate French family for epilepsy drug side effects
PARIS – A French court has ordered Sanofi to pay
France’s Sanofi offers 1.5 billion euro bond linked to access to medicine
(Reuters) – French healthcare group Sanofi said it had priced
Sanofi halts new spending on non-essential drugs in Russia and Belarus
PARIS – French drugmaker Sanofi on Wednesday said it would